These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 6978827
1. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Herlong HF, Recker RR, Maddrey WC. Gastroenterology; 1982 Jul; 83(1 Pt 1):103-8. PubMed ID: 6978827 [Abstract] [Full Text] [Related]
8. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis. Floreani A, Carderi I, Ferrara F, Rizzotto ER, Luisetto G, Camozzi V, Baldo V. Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215 [Abstract] [Full Text] [Related]
13. 25-Hydroxyvitamin D3 treatment of bone disease in primary biliary cirrhosis. Arnaud SB. Gastroenterology; 1982 Jul; 83(1 Pt 1):137-40. PubMed ID: 7075937 [No Abstract] [Full Text] [Related]
14. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study. Benetti A, Crosignani A, Varenna M, Giussani CS, Allocca M, Zuin M, Podda M, Battezzati PM. J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492 [Abstract] [Full Text] [Related]
15. [Bone histology in postmenopausal osteoporosis--variations in cellular activity]. Lozo P, Krpan D, Krvavica A, Vukelić Baturić T, Fistonić I, Kusec V. Acta Med Croatica; 2004 Mar; 58(1):5-11. PubMed ID: 15125387 [Abstract] [Full Text] [Related]
16. Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment. Miki T, Nakatsuka K, Naka H, Masaki H, Imanishi Y, Ito M, Inaba M, Morii H, Nishizawa Y. J Bone Miner Metab; 2004 Mar; 22(6):569-76. PubMed ID: 15490267 [Abstract] [Full Text] [Related]
17. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L. Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487 [Abstract] [Full Text] [Related]
18. Metabolic bone disease in primary biliary cirrhosis at presentation. Mitchison HC, Malcolm AJ, Bassendine MF, James OF. Gastroenterology; 1988 Feb; 94(2):463-70. PubMed ID: 3335317 [Abstract] [Full Text] [Related]
19. Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry. Guichelaar MM, Malinchoc M, Sibonga J, Clarke BL, Hay JE. Hepatology; 2002 Oct; 36(4 Pt 1):895-903. PubMed ID: 12297836 [Abstract] [Full Text] [Related]
20. Bone disease induced by phenytoin therapy: clinical and experimental study. Moro-Alvarez MJ, Díaz Curiel M, de la Piedra C, Mariñoso ML, Carrascal MT. Eur Neurol; 2009 Oct; 62(4):219-30. PubMed ID: 19628941 [Abstract] [Full Text] [Related] Page: [Next] [New Search]